SEARCH

SEARCH BY CITATION

References

  • Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. Ser. B 57:289300.
  • Baker, R. G., and G. A. Koretzky. 2008. Regulation of T cell integrin function by adapter proteins. Immunol. Res. 42:132144.
  • Cecconi, F., S. Di Bartolomeo, R. Nardacci, C. Fuoco, M. Corazzari, L. Giunta, A. Romangnoli, A. Stoykaova, K. Chowdhury, and G. M. Fimia, et al. 2007. A novel role for autophagy in neurodevelopment. Autophagy 3:506508.
  • Craddock, N., M. C. O’Donovan, and M. J. Owen. 2006. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr. Bull. 32:916.
  • De Luca, V., J. Strauss, M. Semeralul, S. Huang, P. P. Li, J. J. Warsh, J. L. Kennedy, and A. H. Wong. 2008. Analysis of BDNF Val66Met allele-specific mRNA levels in bipolar disorder. Neurosci. Lett. 441:22923.
  • Duan, S., R. Gao, Q. Xing, J. Du, Z. Liu, Q. Chen, H. Wang, et al. G. Feng, and L. He. 2005. A family-based association study of schizophrenia with polymorphisms at three candidate genes. Neurosci. Lett. 379:3236.
  • Duman, R. S. 2005. Neurotrophic factors and regulation of mood: role of exercise, diet and metabolism. Neurobiol. Aging 26(Suppl 1):8893.
  • Falasca, M., and T. Maffucci. 2009. Rethinking phosphatidylinositol 3-monophosphate. Biochem. Biophys. Acta. 1793:17951803.
  • Fruman, D. A., R. E. Meyers, and L. C. Cantley. 1998. Phosphoinositide kinases. Annu. Rev. Biochem. 67: 481507.
  • Huang, E. J., and L. F. Reichardt. 2001. Neurotrophins: role in neuronal development and function. Annu. Rev. Neurosci. 24:677736.
  • Kaplan, D. R., and E. Cooper. 2001. PI-3 kinase and IP3: partners in NT3-induced synaptic transmission. Nat. Neurosci. 4:57.
  • Karege, F., G. Perret, G. Bondolfi, M. Schwald, G. Bertschy, and J. M. Aubry. 2002. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109:143148.
  • Lu, B., and K. Martinowich. 2008. Cell biology of BDNF and its relevance to schizophrenia. Novartis Found. Symp. 289:11929. Review.
  • Nurnberger, J. I. Jr., M. C. Blehar, C. A. Kaufmann, C. York-Cooler, S. G. Simpson, J. Harkavy-Friedman, J. B. Severe, D. Malaspina, and T. Reich. 1994. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative. Arch. Gen. Psychiatry 51:849859.
  • Neves-Pereira, M., E. Mundo, P. Muglia, N. King, F. Macciardi, and J. L. Kennedy. 2002. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 71:651655.
  • Preisig, M., B. T. Fenton, M. L. Matthey, A. Berney, and F. Ferrero. 1999. Diagnostic interview for genetic studies (DIGS): inter-rater and test-retest reliability of the French version. Eur. Arch. Psychiatry Clin. Neurosci. 249:174179.
  • Reichardt, L. F. 2006. Neurotrophin-regulated signalling pathways. Philos. Trans. R Soc. Lond. B Biol. Sci. 361:15451564.
  • Saito, T., M. R. Aghalar, and H. M. Lachman. 2005. Analsis of PI3KC3 promoter variant in African-American with schizophrenia. Schizophrenia Res. 76:361362.
  • Simpson, P. J., E. Wang, C. Moon, V. Matarazzo, D. R. Cohen, D. J. Liebl, and G. V. Ronnett. 2003. Neurotrophin-3 signaling maintains maturational homeostasis between neuronal populations in the olfactory epithelium. Mol. Cell Neurosci. 24:858874
  • Shao, L., and M. P. Vawter. 2008. Shared gene expression alterations in schizophrenia and bipolar disorder. Biol. Psychiatry 64:8997.
  • Stopkova, P., T. Saito, D. F. Papolos, J. Vevera, I. Paclt, I. Zukov, Y. B. Berson, B. A. Margolis, R. D. Strous, and H. M. Lachman. 2004. Identification of PIK3C3 promoter variant associated with bipolar disorder and schizophrenia. Biol. Psychiatry 55:981988.
  • Sun C. Y., Y. Hu, J. Huang, Z. B. Chu, L. Zhang, X. M. She, and L. Chen. 2010. Brain-derived neurotrophic factor induces proliferation, migration, and VEGF secretion in human multiple myeloma cells via activation of MEK-ERK and PI3K/AKT signaling. Tumour Biol. 31:121128.
  • Tochigi, M., T. Otowa, M. Suga, M. Rogers, T. Minato, H. Yamasue, K. Kasai, N. Kato, and T. Sasaki. 2006. No evidence for an association between the BDNF Val66Met polymorphism and schizophrenia or personality traits. Schizophr. Res. 87:4547.
  • Toker, A., and L. C. Cantley. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673676.
  • Vanhaesebroeck, B., and M. D. Waterfield. 1999. Signaling by distinct classes of Phosphoinositide 3-kinases. Exp. Cell. Res. 253:239254.
  • Vincze, I., N. Perroud, C. Buresi, P. Baud, F. Bellivier, B. Etain, C. Founier, F. Karege, M. L. Matthey, M. Preisig, et al. 2008. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord. 10:580587.
  • Waite, K., and B. J. Eickholt. 2010. The neurodevelopmental implications of PI3K signaling. Curr. Top. Microbiol. Immunol. 346:245265.
  • Watanabe, Y., T. Muratake, N. Kaneko, A. Nunokawa, and T. Someya. 2006. No association between the brain-derived neurotrophic factor gene and schizophrenia in a Japanese population. Schizophr. Res. 84:2935.
  • Williams, N. M., M. I. Rees, P. Holmans, N. Norton, A. G. Cardno, L. A. Jones, K. C. Murphy, R. D. Sanders, G. McCarthy, M. Y. Gray, et al. 1999. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs. Hum. Mol. Genet. 8:17291739.